Scientific Sample Clauses

Scientific. Atlanta, either by fax or by telephone, will provide Gulf Power Company with a cost/time quote to perform services.
Sample 1Sample 2See All (4)
AutoNDA by SimpleDocs
Scientific. Atlanta will query the caller via telephone to determine the cause of the equipment anomaly.
Sample 1Sample 2
Scientific how many articles, conferences, presentations are given and how many students are trained by this project.
Sample 1
Scientific. Provides expert medical physics advice to clinicians and medical physicists in diagnostic imaging.
Sample 1
Scientific. To create a good environment throughout the EU for development of technologies towards the Near Zero Waste EU it is crucial to have a clear and objective way to validate the possible solutions according to the circumstances within each specific EU country or region. To make sure that development of technology and processes will take into account the impact on environment and health the current used standards for evaluating the sustainability impact should be reviewed. Scientific actions should be made towards the implementation of standards for the use of recycled materials from plastic packaging compared to virgin plastic materials. At this moment there is a big focus on CO2 in a value chain. When we want to come to a Near Zero Waste EU standards will be needed that will address this goal in a scientific way and also incorporate the resource dependency of the EU for plastics. Besides the EU resource policy based on circular economy thinking it is also needed to address the global political situation within such a model. In the past a geographical region had its own local policy regarding resources and development. The influence of one geographical region into another with resources is rapidly increasing with the globalization of companies and business strategies based on influencing global material streams and prices. New value chain/material standards should be developed through scientific approach of this Near Zero Waste EU goals for plastic packaging, with a good focus on the total environmental impact and not only on CO2. Input needed on: What are the main drivers of today’s LCA methodologies What are commonly used methodologies in the value chain of plastic packaging Are there really critical materials from a supply stand of view, and what focus should a new LCA standard have to make sure this is important enough Each pathway should lead into a business case that can stand on its own, without everlasting funding schemes supporting them. This does not mean that there is no funding needed to get the business started. One of the critical aspects in this matter will be volume of material and certainty of procurement of the recovered materials. Besides funding for development, every business has a need for a certain scale of volume to be economically viable. In order to achieve this economic volume it is essential to have a clear view on the volumes of material from waste that can be produced in geographical regions (countries). With that information gove...
Sample 1
Scientific. State of the Art Publications / Conferences Other EU projects
Sample 1
Scientific. 1.1. Participates in the installation, acceptance testing, commissioning and validation of treatment planning systems, treatment machines, dosimetry equipment and imaging apparatus used in radiotherapy. 1.2. Carries out ongoing quality assurance and calibration of all treatment planning systems and processes, treatment machines, dosimetry equipment and imaging apparatus, in accordance with relevant national and international standards and guidelines. 1.3. Practices to ensure the safe and effective delivery of radiotherapy treatment, including but not limited to EBRT (and specialised techniques such as IMRT, VMAT and SABR), brachytherapy, intra-operative radiotherapy, and stereotactic radiotherapy. 1.4. Assists to provide advice on the Radiation Oncology Medical Physics (ROMP) aspects of radiotherapy treatment and planning, and participates in the ongoing verification of radiotherapy treatment delivery. 1.5. Practices in one or more areas of specialty within the ROMP service. 1.6. Assists with the continual improvement of internal policy, protocols, quality assurance procedures and methodologies, to ensure ongoing compliance with regulatory requirements and relevant codes of practice and quality standards. 1.7. Assists to ensure radiation safety regulatory requirements are met and maintained for the public, personnel, and equipment according to hospital radiation safety policies and relevant reporting lines.
Sample 1
AutoNDA by SimpleDocs
Scientific. 1.1. Participates in and provides supervision for the installation, acceptance testing, commissioning and validation of treatment planning systems, treatment machines, dosimetry equipment and imaging apparatus used in radiotherapy. 1.2. Carries out and provides supervision for ongoing quality assurance and calibration of all treatment planning systems and processes, treatment machines, dosimetry equipment and imaging apparatus, in accordance with relevant national and international standards and guidelines. 1.3. Practices to ensure the safe and effective delivery of radiotherapy treatment, including but not limited to EBRT (and specialised techniques such as IMRT, VMAT and SABR), brachytherapy, intra-operative radiotherapy, and stereotactic radiotherapy. 1.4. Provides advice on the Radiation Oncology Medical Physics (ROMP) aspects of radiotherapy treatment and planning, and participates in the ongoing verification of radiotherapy treatment delivery. 1.5. Practices in, takes responsibility for, and coordinates the activities of ROMP staff in one or more areas of specialty within the ROMP service. 1.6. For the area of responsibility, initiates and undertakes continual improvement of internal policy, protocols, quality assurance procedures and methodologies, to ensure ongoing compliance with regulatory requirements and relevant codes of practice and quality standards. 1.7. Ensures radiation safety regulatory requirements are met and maintained for the public, personnel, and equipment according to hospital radiation safety policies and relevant reporting lines, in one or more areas of specialty within the ROMP service.
Sample 1
Scientific. Scientific papers will be written in all relevant work packages by the project research partners, with the aim of publication in open access, high impact, peer-reviewed journals. All the resulting peer-reviewed scientific articles will be published at least in so-called “green” open access, and with preference to “gold” open access especially for key publications. Direct links to the publications will be available on the project website and the Horizon 2020 guidelines on open access to scientific publication and research data will be followed: xxxx://xx.xxxxxx.xx/research/participants/data/ref/h2020/grants_manual/hi/oa_pilot/h2020-hi- oa-pilot-guide_en.pdf.
Sample 1

Related to Scientific

  • Clinical 1.1 Provides comprehensive evidence based nursing care and individual case management to a specific group of patients/clients including assessment, intervention and evaluation. 1.2 Undertakes clinical shifts at the direction of senior staff and the Nursing Director including participation on the on-call/after-hours/weekend roster if required. 1.3 Responsible and accountable for patient safety and quality of care through planning, coordinating, performing, facilitating, and evaluating the delivery of patient care relating to a particular group of patients, clients or staff in the practice setting. 1.4 Monitors, reviews and reports upon the standard of nursing practice to ensure that colleagues are working within the scope of nursing practice, following appropriate clinical pathways, policies, procedures and adopting a risk management approach in patient care delivery. 1.5 Participates in xxxx rounds/case conferences as appropriate. 1.6 Educates patients/carers in post discharge management and organises discharge summaries/referrals to other services, as appropriate. 1.7 Supports and liaises with patients, carers, colleagues, medical, nursing, allied health, support staff, external agencies and the private sector to provide coordinated multidisciplinary care. 1.8 Completes clinical documentation and undertakes other administrative/management tasks as required. 1.9 Participates in departmental and other meetings as required to meet organisational and service objectives. 1.10 Develops and seeks to implement change utilising expert clinical knowledge through research and evidence based best practice. 1.11 Monitors and maintains availability of consumable stock. 1.12 Complies with and demonstrates a positive commitment to Regulations, Acts and Policies relevant to nursing including the Code of Ethics for Nurses in Australia, the Code of Conduct for Nurses in Australia, the National Competency Standards for the Registered Nurse and the Poisons Act 2014 and Medicines and Poisons Regulations 2016. 1.13 Promotes and participates in team building and decision making. 1.14 Responsible for the clinical supervision of nurses at Level 1 and/or Enrolled Nurses/ Assistants in Nursing under their supervision.

  • Professional Development 9.01 Continuous professional development is a hallmark of professional nursing practice. As a self-regulating profession, nursing recognizes the importance of maintaining a dynamic practice environment which includes ongoing learning, the maintenance of competence, career development, career counselling and succession planning. The parties agree that professional development includes a diverse range of activities, including but not limited to formal academic programs; short-term continuing education activities; certification programs; independent learning committee participation. The parties recognize their joint responsibility in and commitment to active participation in the area of professional development.

  • Technical Foreign Affairs Training for professional skills of a specialized nature in the methods and techniques of such fields as foreign languages, foreign culture, intelligence (foreign affairs/intelligence), diplomacy, or strategic studies. Technical

  • Curriculum Development This includes the analysis and coordination of textual materials; constant review of current literature in the field, some of which are selected for the college library collection, the preparation of selective, descriptive materials such as outlines and syllabi; conferring with other faculty and administration on curricular problems; and, the attendance and participation in inter and intra-college conferences and advisory committees.

  • Training and Professional Development 11.1 The Employer will develop and maintain an employee training and development plan and provide such plan to the Union upon request. Staff training is intended to provide an opportunity for classified staff employees for training sponsored by the University Training and Development and the UW Medical Centers Organizational Development and Training. Education/Professional Leave is intended to facilitate employee access to continuing education opportunities. Training and educational/professional leave may be used for the purpose of improving job performance, maintaining and increasing proficiency, preparing staff for greater responsibility, or increasing promotional opportunities within the framework of staff positions available at the University. 11.2 Any release time for training for employees accepted for such classes shall be in accordance with the Executive Order (currently No. 52) governing this matter. In the event that two or more employees request the same training period and supervision must limit the number of persons who may participate at one time due to work requirements, the selection will be made on a mutually agreeable basis within the department. 11.3 The training program is a proper subject for discussion by either departmental or University-wide Joint Union/Management Committees. 11.4 If the Employer requires an employee to receive training, reimbursement will be provided in accordance with the University travel rules. Employee attendance at Employer required training, either during or outside working hours, will be considered time worked and compensated in accordance with the provisions of this Agreement. 11.5 Employee attendance at training not required by the Employer and not covered by Executive Order 52, either on approved leave from or outside of working hours, will be voluntary and not considered time worked.

  • Research Primary Investigator as part of a multi-site study (25 points) • Co-Investigator as part of a multi-site study (20 points) • Primary Investigator of a facility/unit based research study (15 points) • Co-Investigator of a facility/unit based research study (10 points) • Develops a unit specific research proposal (5 points) • Conducts a literature review as part of a research study (5 points)

  • Product Development (a) Supplier may develop enhancements it intends to incorporate into the BioGlue Surgical Adhesive during the term of this Agreement that have potential application to the Company Product (“Enhancements”). Unless otherwise agreed by the parties, at least once every six months during the Term, representatives of each of BioForm and Supplier shall hold a meeting in accordance with Sections 4.4 and 8.4 (the “Product Development Meeting”) at which Supplier will present Enhancements for BioForm to consider for application to the Company Product. At such Product Development Meeting, BioForm will also present its marketing plans (pursuant to Section 4.4) for the period and any information or feedback that BioForm reasonably believes may lead to Improvements. Within 30 calendar days following each Product Development Meeting, Supplier shall deliver a notice to BioForm (the “Enhancements Notice”) that shall describe the Enhancements that were presented by Supplier at such Product Development Meeting. Within 30 calendar days following receipt of the Enhancements Notice, BioForm may notify Supplier in writing if BioForm elects that any Enhancement described in the Enhancements Notice shall become an Improvement. If BioForm does provide such notice to Supplier during such 30-calendar day period, then BioForm and Supplier shall agree on a timeline for implementation of the Improvement in new Product Specifications for Company Product. If BioForm does not provide such a notice, said Enhancement shall not be implemented into the Company Product. The Enhancements Notice may also describe any potential Enhancements presented by Supplier at the Product Development Meeting, but BioForm shall not be required to take any action under this Section 8.4 with respect to such potential Enhancements until such time as they are presented by Supplier as Enhancements at a future Product Development Meeting. All Enhancements and potential Enhancement information provided by Supplier shall be considered Supplier Confidential Information. (b) From time to time, each party may request the other party to participate in joint projects to develop Improvements. Neither party is obligated to participate in such projects, and in each **** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. instance, each party’s decision whether to participate will be made in such party’s sole discretion. If both parties mutually agree to participate in such a project (a “Program”), the parties will promptly prepare a mutually agreeable written development agreement specifying the development activities to be performed by and the research and development tasks assigned to each party (the “Development Agreement”). All allocation of Intellectual Property rights with respect to any Program will be set forth in writing in the Development Agreement. (c) In the absence of a Development Agreement, (i) BioForm and Supplier shall retain joint ownership of Intellectual Property rights in which there is joint inventorship by BioForm (or its Affiliates) and Supplier, as determined in accordance with United States patent law, with Supplier’s rights in such joint ownership being subject to the license rights of BioForm under this Agreement, (ii) any Intellectual Property rights related to the Company Products, Enhancements, and Improvements that are created solely by employees or consultants of Supplier during the Term shall be considered to be Intellectual Property rights of Supplier, subject to the license rights of BioForm under this Agreement, and (iii) any Intellectual Property rights related to the Company Products and Improvements that are created solely by employees or consultants of BioForm or any of its Affiliates during the Term shall be considered to be Intellectual Property rights of BioForm. BioForm hereby grants to Supplier a perpetual, royalty free, world-wide, nonexclusive license to Supplier under such Blocking Intellectual Property to make, use, and sell such Intellectual Property outside the Field. “Blocking Intellectual Property” for the purposes of Section 8.4(c)(iii) shall mean Intellectual Property necessary for Supplier to make, use, or sell SA Product.

  • Professional Development Program (a) The parties agree to continue a Professional Development Program for the maintenance and development of the faculty members' professional competence and effectiveness. It is agreed that maintenance of currency of subject knowledge, the improvement of performance of faculty duties, and the maintenance and improvement of professional competence, including instructional skills, are the primary professional development activities of faculty members. (b) Information collected as part of this program shall be the sole property of the faculty member. This information or any judgments arising from this program shall not be used to determine non-renewal or termination of a faculty member's contract, suspension or dismissal of a faculty member, denial of advancement on the salary scale, nor affect any other administrative decisions pertaining to the promotion or employment status of the faculty member. (c) A joint advisory committee consisting of three regular faculty members who shall be elected by and are P.D. Committee Chairpersons and three administrators shall make recommendations for the operation, financing and management of the Professional Development Program.

  • Technology Discoveries, innovations, Know-How and inventions, whether patentable or not, including computer software, recognized under U.S. law as intellectual creations to which rights of ownership accrue, including, but not limited to, patents, trade secrets, maskworks and copyrights developed under this Agreement.

  • Joint Development If joint development is involved, the Recipient agrees to follow the latest edition of FTA Circular 7050.1, “Federal Transit Administration Guidance on Joint Development.”

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!